A vinyl amine containing polymer comprises randomly distributed repeating monomer units having at least two of the following formulae:

##STR00001## wherein, R1 is a hydrogen atom or a methyl group; and wherein the vinyl amine containing polymer comprises repeating monomer unit III and/or IV in a total amount of from about 1.5 weight percent to about 8 weight percent based on a total weight of the polymer.

Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain crosslinked amine polymers and may be used, for example, to treat diseases or other metabolic conditions in which removal of protons and/or chloride ions from the gastrointestinal tract would provide physiological benefits such as normalizing serum bicarbonate concentrations and the blood pH in an animal, including a human.

Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain crosslinked amine polymers and may be used, for example, to treat diseases or other metabolic conditions in which removal of protons and/or chloride ions from the gastrointestinal tract would provide physiological benefits such as normalizing serum bicarbonate concentrations and the blood pH in an animal, including a human.

Disclosed is a copolymer including a structural unit represented by Chemical Formula 1 capable of improving performance (particularly durability) of an electroluminescent device.

Disclosed is a copolymer including a structural unit represented by Chemical Formula 1 capable of improving performance (particularly durability) of an electroluminescent device.

Disclosed herein are a modified high cis polydiene polymer, processes for preparing the modified high cis polydiene polymer, and tire rubber compositions containing the modified high cis polydiene polymer. The processes make use of a functionalizing compound of formula I or formula II and a coupling agent to prepare the modified high cis polydiene polymer from a quantity of conjugated diene monomer polymerized using a lanthanide-based catalyst system. The modified high cis polydiene polymer includes at least one polymer chain having a residue from the functionalizing compound and a residue from the coupling agent and can be utilized in tire rubber compositions in combination with other ingredients such as fillers.

The present invention relates to a coated article comprising a partial or complete fluorinated coating on the surface of an article, wherein the coating comprises 5 to 99% by weight of a hydrophobic compound, and 1 to 95% by weight of a fluorinated surface effect agent, both based on the total solids weight of the coating, where the hydrophobic compound is selected from a hydrophobic cyclic or acyclic ester alcohol.

The present invention relates to a coated article comprising a partial or complete fluorinated coating on the surface of an article, wherein the coating comprises 5 to 99% by weight of a hydrophobic compound, and 1 to 95% by weight of a fluorinated surface effect agent, both based on the total solids weight of the coating, where the hydrophobic compound is selected from a hydrophobic cyclic or acyclic ester alcohol.

Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain crosslinked amine polymers and may be used, for example, to treat diseases or other metabolic conditions in which removal of protons and/or chloride ions from the gastrointestinal tract would provide physiological benefits such as normalizing serum bicarbonate concentrations and the blood pH in an animal, including a human.

Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain crosslinked amine polymers and may be used, for example, to treat diseases or other metabolic conditions in which removal of protons and/or chloride ions from the gastrointestinal tract would provide physiological benefits such as normalizing serum bicarbonate concentrations and the blood pH in an animal, including a human.